T2 Biosystems Inc. (TTOO)
0.30
0.01 (3.45%)
At close: Jan 15, 2025, 11:42 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -50.08M | -62.00M | -49.24M | -46.80M | -59.01M | -51.15M | -62.43M | -54.80M | -45.29M | -31.39M | -20.61M | -14.46M |
| Depreciation & Amortization | 859.00K | 2.27M | 2.54M | 3.16M | 3.64M | 2.45M | 2.94M | 2.28M | 1.47M | 691.00K | 584.00K | 571.00K |
| Stock-Based Compensation | 4.35M | 6.49M | 7.09M | 3.91M | 5.46M | 9.90M | 4.79M | 4.85M | 4.17M | 1.65M | 578.00K | 403.00K |
| Other Working Capital | -4.27M | -959.00K | -957.00K | -3.05M | 851.00K | -1.66M | 140.00K | 947.00K | 2.52M | 1.27M | 448.00K | 256.00K |
| Other Non-Cash Items | 773.00K | 3.11M | 3.93M | 3.31M | 2.41M | 2.00M | 2.60M | 314.00K | 235.00K | 117.00K | 39.00K | 61.00K |
| Deferred Income Tax | n/a | n/a | -1.02M | -258.00K | 280.00K | 613.00K | 4.81M | 112.00K | n/a | 1K | 536.00K | -51.00K |
| Change in Working Capital | -4.04M | -503.00K | -2.17M | -6.54M | 1.86M | -3.94M | -424.00K | 808.00K | 1.96M | 744.00K | 820.00K | 168.00K |
| Operating Cash Flow | -48.14M | -50.63M | -38.87M | -43.22M | -45.36M | -40.14M | -47.72M | -46.44M | -37.47M | -28.18M | -18.05M | -13.30M |
| Capital Expenditures | -192.00K | -339.00K | -460.00K | -804.00K | -761.00K | -593.00K | -2.48M | -5.49M | -7.97M | -2.08M | -513.00K | -283.00K |
| Acquisitions | n/a | n/a | n/a | 4.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | -50.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 10.00M | 25.25M | 15.25M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 10.00M | 25.25M | -35.46M | n/a | n/a | n/a | n/a | 80.00K | n/a | 80.00K | n/a |
| Investing Cash Flow | -192.00K | 9.66M | 24.79M | -36.26M | -761.00K | -593.00K | -2.48M | -5.49M | -7.89M | -2.08M | -433.00K | -283.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | -882.00K | -1.55M | -1.19M | 11.40M | 9.69M | 15.68M | -848.00K | 4.55M |
| Common Stock Repurchased | n/a | -330.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -43.00K | -108.00K | 567.00K | 296.00K | 582.00K | 1.97M | 1.06M | 40.36M | n/a | n/a | 79.59M | n/a |
| Financial Cash Flow | 52.69M | 29.05M | 20.54M | 85.61M | 6.35M | 49.66M | 18.50M | 51.76M | 45.17M | 73.92M | 38.98M | 4.55M |
| Net Cash Flow | 4.36M | -11.92M | 6.45M | 6.13M | -39.77M | 8.93M | -31.69M | -174.00K | -187.00K | 43.65M | 20.49M | -9.04M |
| Free Cash Flow | -48.33M | -50.97M | -39.33M | -44.02M | -46.12M | -40.73M | -50.19M | -51.93M | -45.44M | -30.27M | -18.57M | -13.59M |